Martha Elizabeth Wingard, PA-C

Martha Wingard practices at Cleveland Clinic Indian River Dermatology - HOPD in Vero Beach, Florida.

Martha Wingard's NPI, 1538564299, was assigned on October 23, 2014. Martha Wingard holds Florida license PA9108153.

Martha Wingard's primary practice is Cleveland Clinic Indian River Dermatology - HOPD, at 1155 35th Ln, Vero Beach, FL 32960.

Martha Wingard's primary practice is Cleveland Clinic Indian River Dermatology - HOPD in Vero Beach, Florida. Martha Wingard is also affiliated with Cleveland Clinic Indian River Hospital. The medical group on file is Vero Orthopaedics. Dmand AI also links Martha Wingard to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Martha Wingard practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical is Martha Wingard's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Martha Wingard is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Martha Wingard is licensed in Florida.

Dmand AI lists arthritis, bursitis, carpal tunnel syndrome, hand joint or tendon inflammation, joint pain, minor injury to a limb, muscle pain, fibromyalgia, and limb pain and traumatic arthropathy among the conditions Martha Wingard treats.

CMS data shows 1,476 Medicare services from Martha Wingard across 17 procedure codes in 2024, for 496 Medicare patients. Medicare paid $69,967 for them. Every service was in an office.

CMS counts 496 Medicare patients who saw Martha Wingard in 2024. The largest group is 75 to 84, with 215 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Martha Wingard's median patient age at 69, with 57% women.

In 2024, Martha Wingard wrote 213 Medicare Part D claims for 155 patients. 100% of them were for generic drugs. CMS names the drug for 181 of them, across 5 drugs with 11 or more claims each, at $793 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Martha Wingard for performance year 2024, reported as part of a group. Martha Wingard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Martha Wingard from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $64.

Martha Wingard is a member of AAPA.